IDXX Q3 2024 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$976M+6.6% YoY

Gross Profit

$596M61.1% margin

Operating Income

$304M31.2% margin

Net Income

$233M23.9% margin

EPS (Diluted)

$2.80

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

$220M

Free Cash Flow

$192M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.7B

Stockholders' Equity

$1.6B

Cash & Equivalents

$309M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$976M	$916M	+6.6%
Gross Profit	$596M	$548M	+8.8%
Operating Income	$304M	$275M	+10.4%
Net Income	$233M	$212M	+9.7%

Revenue Segments

Product

$568M58%

Service

$408M42%

Geographic Segments

UNITED STATES

$638M65%

EMEA

$199M20%

Asia Pacific

$81M8%

CANADA

$37M4%

Latin America

$21M2%